GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ion Beam Applications SA (XBRU:IBAS) » Definitions » Tax Expense

Ion Beam Applications (XBRU:IBAS) Tax Expense : €8.80 Mil (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Ion Beam Applications Tax Expense?

Ion Beam Applications's tax expense for the months ended in Dec. 2023 was €4.19 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2023 was €8.80 Mil.


Ion Beam Applications Tax Expense Historical Data

The historical data trend for Ion Beam Applications's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ion Beam Applications Tax Expense Chart

Ion Beam Applications Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.16 1.13 4.38 -6.49 8.80

Ion Beam Applications Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.28 2.01 -8.50 4.61 4.19

Ion Beam Applications Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €8.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ion Beam Applications  (XBRU:IBAS) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Ion Beam Applications Tax Expense Related Terms

Thank you for viewing the detailed overview of Ion Beam Applications's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Ion Beam Applications (XBRU:IBAS) Business Description

Traded in Other Exchanges
Address
Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World, with REst-of-World sales generating the largest proportion of revenue.

Ion Beam Applications (XBRU:IBAS) Headlines

No Headlines